NEXN and atrial septal defect: Genetic evaluation and testing revealed that the patient harbored a novel truncated variant G100X in NEXN, which is an F-actin binding protein at cell–matrix junctions and is implicated in atrial septal defect (ASD) and cardiomyopathies (13).